Caricamento...
The Pharmacology, Efficacy, and Safety of Rivaroxaban in Obese Patient Populations
Cardiovascular disease (CVD) remains the leading cause of death in the USA. Several risk factors have been identified, and obesity has become one of prominent concern. Excessive weight is considered a risk factor for CVD based on evidence linking it to a hypercoagulable state. Considering the preval...
Salvato in:
| Pubblicato in: | Am J Cardiovasc Drugs |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer International Publishing
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089078/ https://ncbi.nlm.nih.gov/pubmed/32803514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40256-020-00434-w |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|